The New York Times, one of the influential media outlets of the US media, wrote that the US officials regarding Johnson & Johnson’s single-dose Covid-19 vaccine were preparing to call for a break in the vaccine. In the report, it was stated that six women who received the vaccine developed a blood clot problem, and it was underlined that this was a rare event. ‘FDA AND CDC APPROVED STOP PLAN’ It was reported that the…"US Johnson Johnson verdict: May be stopped due to blood clot – Health News"
UK Medicines and Healthcare Products Regulatory Authority (MHRA), 7 people in the UK Oxford University and AstraZeneca developed by corona virus He confirmed that he died of a blood clot that occurred after receiving the vaccine. In total, 30 out of 18 million people vaccinated by March 21 experienced blood clot side effects. MHRA’s written statement to the British press confirmed that in the light of the latest data, 7 people died in the UK…"7 people died of AstraZeneca vaccine in UK from blood clot"
The first statement came from AstraZeneca after 9 countries that are members of the European Union (EU) suspended the use of the vaccine due to the suspicion that the Covid-19 vaccine, developed by Oxford University and AstraZeneca in England, caused blood clotting. AstraZeneca stated in a statement that there is no evidence of the risk of blood clotting caused by the corona virus vaccine. “Analysis of our safety data of more than 10 million records…"“Clot risk” statement from AstraZeneca: No evidence available – Health News"